(17α)-13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol (levonorgestrel impurity T)
CAS: 14507-51-8
Ref. 3D-PAA50751
| 1g | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
- (17α)-13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol
- (8R,9S,13S,14S,17R)-13-ethyl-17-ethynyl-3-methoxy-4,6,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol (non-preferred name)
- 13-Ethyl-3-methoxy-18,19-dinor-17alpha-pregna-2,5(10)-dien-20-yn-17-ol
- 18,19-Dinor-17α-pregna-2,5(10)-dien-20-yn-17-ol, 13-ethyl-3-methoxy-
- 18,19-Dinorpregna-2,5(10)-dien-20-yn-17-ol, 13-ethyl-3-methoxy-, (17α)-
(17α)-13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol (levonorgestrel impurity T) is an analog of levonorgestrel with potent anticancer properties. It has been shown to induce apoptosis in human cancer cell lines by inhibiting kinase and elastase activities. This compound has also been tested against a variety of tumor cell lines and has demonstrated significant anticancer activity. In Chinese hamster ovary cells, levonorgestrel impurity T was found to arrest the cell cycle at the G1 phase, leading to decreased protein synthesis and ultimately cell death. As an inhibitor of kinases and other enzymes involved in cellular signaling pathways, this compound may have potential as a therapeutic agent for the treatment of cancer.
Propriedades químicas
Consulta técnica sobre: 3D-PAA50751 (17α)-13-Ethyl-3-methoxy-18,19-dinorpregna-2,5(10)-dien-20-yn-17-ol (levonorgestrel impurity T)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
